- Home
- LIDR vs ICU Comparison
LIDR vs ICU Comparison
Compare LIDR & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- ICU
- Stock Information
- Founded
- LIDR 2013
- ICU 2018
- Country
- LIDR United States
- ICU United States
- Employees
- LIDR N/A
- ICU N/A
- Industry
- LIDR Auto Parts:O.E.M.
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- LIDR Consumer Discretionary
- ICU Health Care
- Exchange
- LIDR Nasdaq
- ICU Nasdaq
- Market Cap
- LIDR 9.8M
- ICU 10.4M
- IPO Year
- LIDR N/A
- ICU N/A
- Fundamental
- Price
- LIDR $0.71
- ICU $1.19
- Analyst Decision
- LIDR Hold
- ICU
- Analyst Count
- LIDR 1
- ICU 0
- Target Price
- LIDR N/A
- ICU N/A
- AVG Volume (30 Days)
- LIDR 1.2M
- ICU 144.0K
- Earning Date
- LIDR 05-08-2025
- ICU 05-14-2025
- Dividend Yield
- LIDR N/A
- ICU N/A
- EPS Growth
- LIDR N/A
- ICU N/A
- EPS
- LIDR N/A
- ICU N/A
- Revenue
- LIDR $246,000.00
- ICU $428,000.00
- Revenue This Year
- LIDR $2,677.23
- ICU $648.15
- Revenue Next Year
- LIDR $409.09
- ICU $100.00
- P/E Ratio
- LIDR N/A
- ICU N/A
- Revenue Growth
- LIDR N/A
- ICU N/A
- 52 Week Low
- LIDR $0.49
- ICU $1.11
- 52 Week High
- LIDR $4.30
- ICU $13.85
- Technical
- Relative Strength Index (RSI)
- LIDR 50.26
- ICU 36.82
- Support Level
- LIDR $0.71
- ICU $1.13
- Resistance Level
- LIDR $0.84
- ICU $1.34
- Average True Range (ATR)
- LIDR 0.06
- ICU 0.07
- MACD
- LIDR 0.00
- ICU 0.00
- Stochastic Oscillator
- LIDR 49.61
- ICU 28.57
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.